CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Kowa Company Ltd v. Sawai USA Inc.

1:14-cv-00978

Overview

Case Number 1:14-cv-00978
Filing Date 2014-07-24
Status Terminated
Termination Date 2015-02-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Sawai Pharmaceutical Co. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Sawai USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Nissan Chemical Industries Ltd. Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Kowa Pharmaceuticals America Inc. Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Kowa Company Ltd Operating Company

Represented By

2 Attorneys Listed

Denise Seastone Kraft

Barnard, Mezzanotte, Pinnie, Seelaus & Kraft, LLP

Tel: +1 (302) 594-4535
Fax: +1 (610) 565-3309

1205 N. Orange Street, Wilmington, DE 19801

Brian A. Biggs

DLA Piper LLP

Tel: +1 (302) 468-5661

1201 N. Market Street, Suite 2100, Wilmington, DE 19801

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials 3 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (5 found):
PTAB: 3 U.S. Courts: 2
USPTO PTAB Trial 2015-07-31
IPR2015-01648

Sawai USA, Inc. et al. v. Nissan Chemical Industries Ltd. et al.

U.S. Continuation Sibling (5856336)
Status: Institution Denied
USPTO PTAB Trial 2015-07-31
IPR2015-01647

Sawai USA, Inc. et al. v. Nissan Chemical Industries Ltd. et al.

U.S. Continuation Sibling (5856336)
Status: Institution Denied
USPTO PTAB Trial 2015-04-18
IPR2015-01069

Mylan Pharmaceuticals Inc. v. Nissan Chemical Industries, Ltd. et al.

U.S. Continuation Sibling (5856336)
Status: Institution Denied
U.S. District Court 2017-06-14
1:17-cv-00762

Kowa Company, Ltd. v. Hetero Drugs Limited

U.S. Family Sibling (["US8557993"])
Status: DED
U.S. District Court 2014-10-02
1:14-cv-01264

Kowa Company Ltd. v. Apotex Inc.

U.S. Family Sibling (["US8557993"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5856336
Quinoline type mevalonolactones
Filed: 1992-05-15
Issued: 1999-01-05
Expired (Term Ended) +3153d PTA
Expires: 2021-01-01
US6465477
Stable pharmaceutical composition
Filed: 1999-11-08
Issued: 2002-10-15
Expired (Term Ended)
Expires: 2019-11-08
US8557993
Crystalline forms of pitavastatin calcium
Filed: 2012-10-31
Issued: 2013-10-15
Active (5.9 yrs remaining)
Expires: 2032-10-31

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+3153 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(10 total)
Pleading / Complaint

COMPLAINT - filed against Sawai Pharmaceutical Co., Sawai USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400.00, receipt number 0311-1559587.) - filed by Kowa Pharmaceuticals America Inc., Kowa Company Ltd, Nissan Chemical Industries Ltd. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Certificate of Compliance C, # 4 Civil Cover Sheet)(etg) (Entered: 07/25/2014)

Entry #1 • 2014-07-24
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (etg) (Entered: 07/25/2014)

Entry #2 • 2014-07-24
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/09/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 12/9/2016. (etg) (Entered: 07/25/2014)

Entry #3 • 2014-07-24
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,856,336; 6,465,477; 8,557,993. (etg) (Entered: 07/25/2014)

Entry #4 • 2014-07-24
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Kowa Pharmaceuticals America Inc. for Kowa Company Ltd filed by Kowa Company Ltd, Kowa Pharmaceuticals America Inc., Nissan Chemical Industries Ltd.. (etg) (Entered: 07/25/2014)

Entry #5 • 2014-07-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc